CORONA Remedies Pledges ₹25 Crore Towards CSR Initiatives in Celebration of 20th Anniversary
CORONA Remedies Limited, a distinguished name in India’s pharmaceutical industry, has announced an ambitious commitment of ₹25 crore for Corporate […]
CORONA Remedies Limited, a distinguished name in India’s pharmaceutical industry, has announced an ambitious commitment of ₹25 crore for Corporate […]
India’s journey toward building a healthier nation is a story of resilience, innovation, and commitment. Over the past decade, the […]
Alkem Laboratories Ltd. has launched MediSamvad, a pioneering digital platform designed to equip healthcare professionals (HCPs) with the latest global […]
Maxivision Super Speciality Eye Hospital, one of India’s premier eye care networks, has announced an ambitious expansion plan in Gujarat […]
Metropolis Healthcare Limited, one of India’s leading diagnostic service providers, has launched the innovative UltraTouch™ Push Button Blood Collection Set […]
Lupin Limited, a global pharmaceutical leader, has announced the strategic acquisition of three prominent anti-diabetes trademarks—Gibtulio, Gibtulio Met, and Ajaduo—from […]
The All India Institute of Medical Sciences (AIIMS), New Delhi, and Wipro GE Healthcare have signed a Memorandum of Understanding […]
In a groundbreaking development for diabetes research, India’s first Diabetes Biobank has been set up in Chennai through a collaboration […]
In a significant move for India’s healthtech ecosystem, Infosys has announced an investment of INR 8.3 crore (approximately $1 million) […]
The healthcare innovation industry is set to benefit from a groundbreaking advancement by scientists at the Jawaharlal Nehru Centre for […]
As the healthcare industry embraces digital transformation, it faces a dual challenge: harnessing advanced technologies to improve patient outcomes while […]
In a significant milestone for India’s healthcare system, a total of 16,586 public health facilities have been certified under the […]
India’s pharmaceutical landscape witnessed a series of proactive measures in 2023-24, addressing critical issues like drug quality, combating spurious and […]